Mammotome a Division of Devicor Medical Products Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Mammotome a Division of Devicor Medical Products's estimated annual revenue is currently $172.7M per year.(i)
  • Mammotome a Division of Devicor Medical Products's estimated revenue per employee is $251,000

Employee Data

  • Mammotome a Division of Devicor Medical Products has 688 Employees.(i)
  • Mammotome a Division of Devicor Medical Products grew their employee count by 6% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$464.4M185024%N/AN/A
#2
$16.6M6618%N/AN/A
#3
$7.8M310%N/AN/A
#4
$3.8M150%N/AN/A
#5
$19.1M763%N/AN/A
#6
$70M2798%N/AN/A
#7
$4.5M18-14%N/AN/A
#8
$135.3M5390%N/AN/A
#9
$10M40-9%N/AN/A
#10
$8M3223%N/AN/A
Add Company

In 1995, Mammotome was introduced as the first vacuum-assisted breast biopsy system. Two years later, the Mammotome Biopsy System was acquired by Ethicon Endo-Surgery (EES). EES continued to develop the Mammotome Biopsy System, creating additional image-guided products and developing the Mammotome brand into the worldwide market leader. In July 2010, Devicor acquired the Breast Care Business from EES. Devicor focuses exclusively on medical technologies that improve patient experiences and outcomes. Over the next several years, Devicor Medical launched two new innovative vacuum-assisted breast biopsy systems and acquired several other products to create a robust breast care product portfolio. In December 2014, Devicor Medical Products, Inc. was acquired by Leica Biosystems (LBS), which is part of the Danaher family of companies. LBS is the global leader in anatomic pathology solutions and automation. At LBS, we believe A patient's breast cancer diagnosis begins with the right tissue. In the biopsy suite, we proudly partner with our customers to provide our Mammotome biopsy solutions. In the Operating Room, we have gone from the benchmark in gamma detection to the forefront of next generation magnetic targeting. We are proud to offer the products and solutions that help clinicians provide a better experience for the patient. Headquartered in Cincinnati, OH, the Mammotome brand is sold in over 50 different countries throughout the world. With employees located in 11 countries, we are a global organization all dedicated to one mission: Advancing Cancer Diagnostics, Improving Lives. Our company is committed to advancing technology for the early detection of breast cancer, providing support and education for clinicians worldwide, and offering breast care information for patients. As part of LBS, we offer substantial opportunity for growth and development, with career opportunities located throughout the United States or abroad.

keywords:Biotechnology,Cleantech,Hardware,Hardware Peripherals,Healthcare,Medical Devices,Medical Diagnostics,Pharmaceuticals,Wind Power

N/A

Total Funding

688

Number of Employees

$172.7M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$190M69113%N/A
#2
$282.2M69919%N/A
#3
$260.7M7573%N/A
#4
$171.6M8171%N/A
#5
$311.1M823-3%N/A